Comment on: the effect of semaglutide and GLP-1 RAs on risk of nonarteritic anterior ischemic optic neuropathy [published online ahead of print June 20, 2025]
The peptide has demonstrated stability in gastric acid environments, which is relevant to oral bioavailability research, though the primary route studied in published multi-peptide protocols involves parenteral application in animal models [3]
Br J Anaesth 98(6):775784
Prioritizing consistent sleep schedules and good sleep hygiene further enhances these benefits
A lack of sleep can reduce tolerance, meaning you might experience impairment at a lower BAC level
To view or add a comment, sign in More Relevant Posts It was great working with Stacie Dusetzina, Jihye Han, Jinyi Zhu, and Ashley Leech on this piece out in JAMA today